Back to Search
Start Over
Labelling of Biosimilars.
- Source :
- Pharmaceutical Technology Europe; Feb2015, Vol. 27 Issue 2, p18-19, 2p
- Publication Year :
- 2015
-
Abstract
- The article reports that the European Medicines Agency (EMA) is under pressure to exert tighter standards on biosimilars that are marketed in Europe as of 2015. Topics include the number of regulatory issues with biosimilars that need to be resolved by EMA, the argument of the opponents of EMA's position that biosimilars' labelling should focus on the quality characteristics, and the disagreements over labelling in the European Union.
- Subjects :
- DRUG labeling
MEDICAL supplies
DRUG marketing
Subjects
Details
- Language :
- English
- ISSN :
- 17537967
- Volume :
- 27
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- Pharmaceutical Technology Europe
- Publication Type :
- Periodical
- Accession number :
- 102244718